These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 1375714)
21. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Buettner H; Bartley GB Am J Ophthalmol; 1992 Jun; 113(6):669-73. PubMed ID: 1317993 [TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance evaluation of fibrovascular ingrowth into porous polyethylene orbital implant. Park SW; Seol HY; Hong SJ; Kim KA; Choi JC; Cha IH Clin Imaging; 2003; 27(6):377-81. PubMed ID: 14585562 [TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance imaging of orbital lymphangioma with and without gadolinium contrast enhancement. Bond JB; Haik BG; Taveras JL; Francis BA; Numaguchi Y; Mihara F; Gupta KL Ophthalmology; 1992 Aug; 99(8):1318-24. PubMed ID: 1513586 [TBL] [Abstract][Full Text] [Related]
24. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions. De Potter P; Flanders AE; Shields JA; Shields CL; Gonzales CF; Rao VM Arch Ophthalmol; 1994 Mar; 112(3):340-8. PubMed ID: 8129659 [TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance imaging assessment of fibrovascular ingrowth into porous polyethylene orbital implants. Choi HY; Lee JS; Park HJ; Oum BS; Kim HJ; Park DY Clin Exp Ophthalmol; 2006; 34(4):354-9. PubMed ID: 16764656 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of biomatrix hydroxyapatite ocular implants with technetium-99m-MDP. Baumgarten D; Wojno T; Taylor A J Nucl Med; 1993 Mar; 34(3):467-8. PubMed ID: 8382742 [TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging in choroidal osteoma. DePotter P; Shields JA; Shields CL; Rao VM Retina; 1991; 11(2):221-3. PubMed ID: 1925087 [TBL] [Abstract][Full Text] [Related]
32. Fibrovascular ingrowth into porous polyethylene orbital implants (Medpor) after modified evisceration. Huang D; Xu B; Yang Z; Xu B; Lin X; Yang X; Zhao J Ophthalmic Plast Reconstr Surg; 2015; 31(2):139-44. PubMed ID: 25025383 [TBL] [Abstract][Full Text] [Related]
33. Hydroxyapatite implants--a new trend in enucleation and orbital reconstructive surgery. Albiar E Insight; 1992 Apr; 17(1):25-8. PubMed ID: 1564367 [TBL] [Abstract][Full Text] [Related]
34. Hydroxyapatite orbital implant abscess: histopathologic correlation of an infected implant following evisceration. Ainbinder DJ; Haik BG; Tellado M Ophthalmic Plast Reconstr Surg; 1994 Dec; 10(4):267-70. PubMed ID: 7865449 [TBL] [Abstract][Full Text] [Related]
36. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases. Shields CL; Shields JA; De Potter P; Singh AD Trans Am Ophthalmol Soc; 1993; 91():177-89; discussion 189-95. PubMed ID: 8140690 [TBL] [Abstract][Full Text] [Related]
37. Orbital development in survivors of retinoblastoma treated by enucleation with hydroxyapatite implant. Lin HY; Liao SL Br J Ophthalmol; 2011 May; 95(5):630-3. PubMed ID: 20852319 [TBL] [Abstract][Full Text] [Related]
38. Orbital involvement in Waldenström's macroglobulinemia: ultrasound, computed tomography and magnetic resonance findings. Ettl AR; Birbamer GG; Philipp W Ophthalmologica; 1992; 205(1):40-5. PubMed ID: 1436990 [TBL] [Abstract][Full Text] [Related]
39. Coralline hydroxyapatite spheres as secondary orbital implants in anophthalmos. Massry GG; Holds JB Ophthalmology; 1995 Jan; 102(1):161-6. PubMed ID: 7831032 [TBL] [Abstract][Full Text] [Related]
40. Hydroxyapatite orbital implant after enucleation--experience with 200 cases. Shields JA; Shields CL; De Potter P Mayo Clin Proc; 1993 Dec; 68(12):1191-5. PubMed ID: 8246621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]